What We Do

Kalia Health is a biotechnology startup dedicated to developing women and birthing people’s healthcare technologies for use in low-resource settings in the United States and globally. Through our development of the home-based KAL-PDx which detects complications like preeclampsia and eclampsia early on, we aim to improve maternal health outcomes and provide women and birthing people with the tools they need to take control of their own health.

Kalia Health

Early screening for pre-eclampsia is vital for the health of both the pregnant individual and their baby. Detecting signs early allows healthcare providers to implement interventions, reducing the risk of serious complications such as eclampsia and fetal growth restriction. Regular prenatal check-ups enable timely intervention, safeguarding the well-being of both mother and child.

Burden of Disease

Protein detection in urine tests play a critical role in the early detection of pre-eclampsia during pregnancy. These tests are typically conducted during routine prenatal visits. Kalia Health works to provide at-home urine detection tests in order to detect elevated levels of protein in the urine. These proteins can signal potential kidney dysfunction, a hallmark feature of preeclampsia. Timely detection through these tests allows for prompt intervention and management of the condition, reducing the risk of complications for both the mother and baby. Regular screening for preeclampsia is therefore essential in ensuring the optimal health and safety of pregnant individuals and their unborn children.

KAL-PDx Tech

Meet the Team

Management Team

Denali Dahl (she/her)

Chief Executive Officer and Co-Founder

Happy Ghosh (she/her)

Chief Product Officer and Co-Founder

Jamison Sexton (he/him)

Chief Business Officer

The Team

  • Jon McDunn, PhD

    Diagnostic Development & Commercialization Specialist

    LinkedIn

  • Thomas Dahl, PhD

    Scientific & Regulatory Specialist

    LinkedIn

  • Alan Rosenbaum, MD

    OB/GYN Hospitalist at UNC Rex Hospital

    LinkedIn

  • Elizabeth Ndichu, MD

    Clinical & Research Analytics Specialist

    LinkedIn
  • Neyha Baddigam

    Neyha Baddigam

    Product Management Intern

    LinkedIn

  • Sruthi Potluru

    Clinical and Regulatory Research Intern

    LinkedIn

Recent Press

RECENT PRESS

Featured
Social Justice Innovation Award
Social Justice Innovation Award

Kalia Health is proud to be a winner of the Social Justice Innovation Award, sponsored by Morgan Stanley and Centri Tech Foundation! The Social Justice Innovation Award aims to advance systemic solutions for social and racial justice. Kalia Health will have a nine-month partnership with Centri Tech Foundation and a cohort experience with fellow award winners. Kalia Health will also receive coaching, support, access to professional networks, and a $250,000 award.

Read More →
IndieBio
IndieBio

Kalia Health has been selected for IndieBio’s accelerator program! IndieBio is #1 in Early Stage Biotechnology, where 200+ companies have developed through the program. IndieBio has a rich alumni network and diversity in the companies and people supported. Through this program, Kalia Health will have opportunities to partner with global investors, as well as networking and mentoring opportunities.

Read More →
TigerLaunch
TigerLaunch

TigerLaunch is the world’s largest student-run entrepreneurship competition. TigerLaunch has regional contests worldwide, where winners receive access to a network of internal companies of various areas, mentorships from leaders and venture capitalists, and funding. Kalia Health is proud to be a winner of the Howard Cox ‘64 Entrepreneurship Prize!

Read More →